Fulcrum Therapeutics, Inc. (FULC)
3.695
+0.02
(+0.68%)
USD |
NASDAQ |
Oct 08, 12:32
Fulcrum Therapeutics Market Cap : 281.87M for Oct. 8, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 07, 2026 | 279.97M |
| October 06, 2026 | 281.49M |
| October 05, 2026 | 283.02M |
| October 02, 2026 | 281.49M |
| October 01, 2026 | 280.73M |
| September 30, 2026 | 282.26M |
| September 29, 2026 | 282.26M |
| September 28, 2026 | 283.78M |
| September 25, 2026 | 285.31M |
| September 24, 2026 | 288.74M |
| September 23, 2026 | 290.65M |
| September 22, 2026 | 292.94M |
| September 21, 2026 | 289.88M |
| September 18, 2026 | 286.83M |
| September 17, 2026 | 287.60M |
| September 16, 2026 | 289.12M |
| September 15, 2026 | 288.36M |
| September 14, 2026 | 289.12M |
| September 11, 2026 | 289.88M |
| September 10, 2026 | 289.88M |
| September 09, 2026 | 292.94M |
| September 08, 2026 | 291.41M |
| September 04, 2026 | 293.70M |
| September 03, 2026 | 292.94M |
| September 02, 2026 | 293.70M |
| Date | Value |
|---|---|
| September 01, 2026 | 295.22M |
| August 31, 2026 | 296.75M |
| August 28, 2026 | 293.70M |
| August 27, 2026 | 293.70M |
| August 26, 2026 | 294.46M |
| August 25, 2026 | 294.46M |
| August 24, 2026 | 292.94M |
| August 21, 2026 | 292.17M |
| August 20, 2026 | 293.70M |
| August 19, 2026 | 298.28M |
| August 18, 2026 | 295.22M |
| August 17, 2026 | 292.94M |
| August 14, 2026 | 285.31M |
| August 13, 2026 | 283.02M |
| August 12, 2026 | 283.78M |
| August 11, 2026 | 281.49M |
| August 10, 2026 | 286.07M |
| August 07, 2026 | 296.75M |
| August 06, 2026 | 287.60M |
| August 05, 2026 | 287.60M |
| August 04, 2026 | 289.88M |
| August 03, 2026 | 283.02M |
| July 31, 2026 | 273.10M |
| July 30, 2026 | 283.78M |
| July 29, 2026 | 276.15M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cocrystal Pharma, Inc. | 14.62M |
| CNBX Pharmaceuticals, Inc. | 0.2361M |
| Arvinas, Inc. | 475.38M |
| Definium Therapeutics, Inc. | 4.450B |
| LeonaBio, Inc. | 54.65M |
Market Cap Related Metrics
| Price to Book Value | 0.9072 |
| Price | 3.695 |
| Earnings Yield | -32.84% |